441:
332:
460:
579:
together with Jérôme Van
Biervliet, Christine Durinx continues to shape the landscape of biotechnology in Flanders, Belgium. VIB supports top-tier research, founds spin-offs, and provides the ecosystem with access to innovation, technology, and talent. Christine Durinx has the mission to establish a
525:, a life science research institute in Flanders, Belgium. She started her career in Belgium in the pharmaceutical industry and then moved to the Geneva region. She worked in Switzerland for over 10 years, both in the pharmaceutical industry and in the
567:
data platform. Her work on the sustainability of research data infrastructures contributed to the establishment of the ELIXIR core data resources, and later the Global core biodata resources. In 2021, Deep
Knowledge Analytics
229:
tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the
549:
After completing her education, Christine Durinx embarked on a successful career in the pharmaceutical industry. In 2009, she moved to the Lake Geneva region with her family.
864:
426:
of the subject can be established. If you still feel that this subject is worthy of inclusion in
Knowledge, please rewrite your submission to comply with these policies.
869:
773:
400:
74:
703:
Durinx, Christine; McEntyre, Jo; Appel, Ron; Apweiler, Rolf; Barlow, Mary; Blomberg, Niklas; Cook, Chuck; Gasteiger, Elisabeth; Kim, Jee-Hyub (2017-03-09).
889:
859:
835:
879:
595:
685:
591:
Christine Durinx is an advocate for diversity, among others by mentoring young scientists and encouraging them to take on leadership roles.
576:
418:, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Knowledge's
639:"Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV"
163:
553:
526:
508:
267:
187:
245:
874:
541:
where she also received her PhD in
Pharmaceutical sciences, on the structure and function of the enzyme dipeptidyl-peptidase-IV.
884:
482:
411:
396:
380:
175:
70:
54:
529:, a non-profit foundation that is a pioneer in databases, software tools and data science services for the life sciences.
392:
387:
181:
131:
98:
66:
61:
588:, the alliance of research institutes advocating for excellent research in Europe, in which VIB is a founding partner.
817:
208:
135:
from experienced editors. These venues are only for help with editing and the submission process, not to get reviews.
415:
374:
48:
490:
486:
470:
419:
212:
193:
85:
If you have not resolved the issues listed above, your draft will be declined again and potentially deleted.
619:
403:
when addressing this issue). If no additional references exist, the subject is not suitable for
Knowledge.
281:
82:
If you would like to continue working on the submission, click on the "Edit" tab at the top of the window.
77:
when addressing this issue). If no additional references exist, the subject is not suitable for
Knowledge.
29:
538:
271:
226:
147:
423:
362:
36:
355:
666:
599:
552:
After several years in the Swiss pharmaceutical industry, in 2014, Christine Durinx joined the
736:
658:
395:). Before any resubmission, additional references meeting these criteria should be added (see
299:
69:). Before any resubmission, additional references meeting these criteria should be added (see
726:
716:
650:
637:
Lambeir, Anne-Marie; Durinx, Christine; Scharpé, Simon; De
Meester, Ingrid (January 2003).
143:
215:
to find examples of
Knowledge's best writing on topics similar to your proposed article.
638:
731:
704:
407:
105:
Please do not remove reviewer comments or this notice until the submission is accepted.
836:"Beslissingen Vlaamse Regering - Economie, Wetenschap en Innovatie (08 december 2023)"
853:
169:
670:
150:. Some WikiProjects are more active than others so a speedy reply is not guaranteed.
754:
200:
197:
721:
410:
than an entry in an encyclopedia. Encyclopedia articles need to be written from a
537:
Christine Durinx grew up in
Antwerp, Belgium. She graduated in Pharmacy from the
440:
331:
322:
Please note that if the issues are not fixed, the draft will be declined again.
142:, or if the review is taking a lot of time, you can try asking for help on the
755:"Artificial Intelligence Industry in Switzerland Landscape Overview 2021 Q4"
557:
840:
Government of
Flanders, Department of Economy, Science and Innovation (EWI)
740:
662:
774:"Christine Durinx nieuwe codirecteur Vlaams Instituut voor Biotechnologie"
572:) included Christine Durinx in the list of AI influencers in Switzerland.
556:
Between July 2018 and March 2022, the SIB was led by Christine Durinx and
654:
225:
To improve your odds of a faster review, tag your draft with relevant
791:
564:
686:"Cette expertise en bioinformatique est une spécialité de la Suisse"
291:
24:
489:
external links, and converting useful links where appropriate into
521:
Christine Durinx is a Belgian Pharmacist and Managing Director of
431:
350:
453:
341:
15:
439:
330:
569:
369:
coverage (not just passing mentions) about the subject in
361:
This submission's references do not show that the subject
43:
coverage (not just passing mentions) about the subject in
35:
This submission's references do not show that the subject
478:
314:
303:
123:
90:
585:
575:
Since April 2022, serving as the Managing Director of
580:
new research center in AI and computational biology (
620:"Christine Durinx joins VIB as co-managing director"
581:
522:
348:Submission declined on 15 January 2024 by
594:She is a member of the Board of Directors of the
473:may not follow Knowledge's policies or guidelines
643:Critical Reviews in Clinical Laboratory Sciences
584:). She is a member of the Board of Directors of
22:Submission declined on 21 April 2024 by
598:, as well as of the Board of Directors of the
8:
451:Pharmaceutical scientist and director of VIB
166:– a basic overview on how to edit Knowledge.
730:
720:
577:VIB (Flemish Institute for Biotechnology)
509:Learn how and when to remove this message
865:AfC submissions by date/06 February 2024
705:"Identifying ELIXIR Core Data Resources"
554:Swiss Institute of Bioinformatics (SIB).
416:independent, reliable, published sources
870:AfC submissions by date/15 January 2024
611:
527:Swiss Institute of Bioinformatics (SIB)
563:While at SIB, she co-led the European
393:guidelines on the notability of people
221:Improving your odds of a speedy review
67:guidelines on the notability of people
7:
684:Marenne, Sophie (5 September 2019).
164:Knowledge:Contributing to Knowledge
196:– make sure your article includes
14:
890:AfC submissions on living persons
860:AfC G13 eligible soon submissions
414:, and should refer to a range of
363:qualifies for a Knowledge article
188:Knowledge:Writing better articles
37:qualifies for a Knowledge article
880:Draft articles on Western Europe
560:, as Joint Executive Directors.
458:
119:editing or submitting your draft
772:Schoofs, Nico (20 April 2022).
408:read more like an advertisement
88:If you need extra help, please
818:"De balans | Christine Durinx"
596:Research Foundation - Flanders
176:Help:Referencing for beginners
1:
722:10.12688/f1000research.9656.2
190:– how to improve your article
184:– how to develop your article
182:Knowledge:Article development
816:Voet, Bert (23 April 2022).
792:"EU-LIFE Board of Directors"
129:at the AfC Help Desk or get
96:at the AfC Help Desk or get
406:This submission appears to
365:—that is, they do not show
209:Knowledge:Featured articles
178:– how to include references
39:—that is, they do not show
906:
102:from experienced editors.
759:Deep Knowledge Analytics
533:Early life and education
391:of the subject (see the
302:5 months ago. Reviewer:
65:of the subject (see the
875:Draft articles on women
213:Knowledge:Good articles
194:Knowledge:Verifiability
172:– how to use the markup
885:Draft articles on STEM
444:
335:
248:Add tags to your draft
157:How to improve a draft
140:feedback on your draft
539:University of Antwerp
443:
412:neutral point of view
334:
600:Born-Bunge Institute
479:improve this article
420:verifiability policy
207:You can also browse
148:relevant WikiProject
491:footnote references
201:third-party sources
842:. 8 December 2023.
445:
435: 8 months ago.
336:
295: 5 months ago.
655:10.1080/713609354
519:
518:
511:
449:
448:
436:
429: Declined by
401:mistakes to avoid
385:sources that are
340:
339:
326:
325:
307:
296:
289: Declined by
125:ask us a question
117:If you need help
112:Where to get help
92:ask us a question
75:mistakes to avoid
59:sources that are
897:
844:
843:
832:
826:
825:
813:
807:
806:
804:
802:
788:
782:
781:
769:
763:
762:
761:. November 2021.
751:
745:
744:
734:
724:
715:(5:2422): 2422.
700:
694:
693:
681:
675:
674:
634:
628:
627:
626:. 20 April 2022.
616:
514:
507:
503:
500:
494:
462:
461:
454:
434:
428:
399:and learn about
359:
353:
342:
319:
317:
310:
309:
297:
294:
288:
258:Editor resources
252:
250:
239:Women scientists
128:
95:
73:and learn about
33:
27:
16:
905:
904:
900:
899:
898:
896:
895:
894:
850:
849:
848:
847:
834:
833:
829:
815:
814:
810:
800:
798:
790:
789:
785:
771:
770:
766:
753:
752:
748:
702:
701:
697:
683:
682:
678:
636:
635:
631:
618:
617:
613:
608:
547:
535:
515:
504:
498:
495:
476:
467:This article's
463:
459:
452:
430:
427:
404:
349:
347:
327:
315:
313:
298:Last edited by
290:
287:
286:
259:
255:
254:
253:
246:
244:
222:
218:
217:
205:
158:
154:
153:
122:
113:
109:
108:
89:
78:
23:
21:
12:
11:
5:
903:
901:
893:
892:
887:
882:
877:
872:
867:
862:
852:
851:
846:
845:
827:
808:
783:
764:
746:
695:
676:
649:(3): 209–294.
629:
610:
609:
607:
604:
546:
543:
534:
531:
517:
516:
471:external links
466:
464:
457:
450:
447:
446:
437:
405:
397:technical help
360:
345:
338:
337:
328:
324:
323:
320:
308:
285:
284:
260:
257:
256:
243:
223:
220:
219:
204:
203:
191:
185:
179:
173:
167:
160:
159:
156:
155:
152:
151:
136:
114:
111:
110:
107:
106:
103:
86:
83:
79:
71:technical help
34:
19:
13:
10:
9:
6:
4:
3:
2:
902:
891:
888:
886:
883:
881:
878:
876:
873:
871:
868:
866:
863:
861:
858:
857:
855:
841:
837:
831:
828:
823:
819:
812:
809:
797:
793:
787:
784:
779:
775:
768:
765:
760:
756:
750:
747:
742:
738:
733:
728:
723:
718:
714:
710:
709:F1000Research
706:
699:
696:
691:
687:
680:
677:
672:
668:
664:
660:
656:
652:
648:
644:
640:
633:
630:
625:
621:
615:
612:
605:
603:
601:
597:
592:
589:
587:
583:
578:
573:
571:
566:
561:
559:
555:
550:
544:
542:
540:
532:
530:
528:
524:
513:
510:
502:
492:
488:
487:inappropriate
484:
480:
474:
472:
465:
456:
455:
442:
438:
433:
425:
421:
417:
413:
409:
402:
398:
394:
390:
389:
384:
383:
378:
377:
372:
368:
364:
357:
352:
346:
344:
343:
333:
329:
321:
318:
312:
311:
305:
304:Inform author
301:
293:
283:
282:Fix bare URLs
280:
277:
273:
269:
265:
262:
261:
251:
249:
242:
240:
236:
232:
228:
216:
214:
210:
202:
199:
195:
192:
189:
186:
183:
180:
177:
174:
171:
170:Help:Wikitext
168:
165:
162:
161:
149:
145:
141:
137:
134:
133:
127:
126:
120:
116:
115:
104:
101:
100:
94:
93:
87:
84:
81:
80:
76:
72:
68:
64:
63:
58:
57:
52:
51:
46:
42:
38:
31:
26:
20:
18:
17:
839:
830:
821:
811:
799:. Retrieved
795:
786:
777:
767:
758:
749:
712:
708:
698:
689:
679:
646:
642:
632:
623:
614:
593:
590:
574:
562:
551:
548:
536:
520:
505:
499:January 2024
496:
481:by removing
468:
386:
381:
375:
370:
366:
300:ToadetteEdit
292:ToadetteEdit
278:
275:
268:Citation bot
263:
247:
238:
234:
230:
224:
206:
139:
138:If you need
130:
124:
118:
97:
91:
60:
55:
49:
44:
40:
25:ToadetteEdit
388:independent
367:significant
227:WikiProject
62:independent
41:significant
854:Categories
801:15 January
606:References
424:notability
264:Easy tools
558:Ron Appel
483:excessive
432:Lopifalko
382:secondary
371:published
351:Lopifalko
279:Advanced:
235:Astronomy
231:Biography
144:talk page
132:live help
121:, please
99:live help
56:secondary
45:published
741:27803796
671:35373216
663:12892317
422:and the
376:reliable
316:Resubmit
198:reliable
50:reliable
822:de tijd
796:EU-LIFE
778:de tijd
732:5070591
586:EU-LIFE
477:Please
469:use of
270: (
739:
729:
669:
661:
582:VIB.AI
565:ELIXIR
545:Career
241:tags.
237:, and
690:Agefi
667:S2CID
146:of a
803:2024
737:PMID
659:PMID
356:talk
272:help
211:and
30:talk
727:PMC
717:doi
651:doi
624:VIB
570:DKA
523:VIB
485:or
856::
838:.
820:.
794:.
776:.
757:.
735:.
725:.
711:.
707:.
688:.
665:.
657:.
647:40
645:.
641:.
622:.
602:.
379:,
373:,
358:).
274:)
266::
233:,
53:,
47:,
32:).
824:.
805:.
780:.
743:.
719::
713:5
692:.
673:.
653::
568:(
512:)
506:(
501:)
497:(
493:.
475:.
354:(
306:.
276:|
28:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.